Back to Search Start Over

Supervised Exercise Immediately After Bariatric Surgery: the Study Protocol of the EFIBAR Randomized Controlled Trial.

Authors :
Artero, Enrique G.
Ferrez-Márquez, Manuel
Torrente-Sánchez, María José
Martínez-Rosales, Elena
Carretero-Ruiz, Alejandro
Hernández-Martínez, Alba
López-Sánchez, Laura
Esteban-Simón, Alba
Romero del Rey, Andrea
Alcaraz-Ibáñez, Manuel
Rodríguez-Pérez, Manuel A.
Villa-González, Emilio
Barranco-Ruiz, Yaira
Martínez-Forte, Sonia
Castillo, Carlos
Gómez Navarro, Carlos
Aceituno Cubero, Jesús
Reyes Parrilla, Raúl
Aparicio Gómez, José A.
Femia, Pedro
Source :
Obesity Surgery; Oct2021, Vol. 31 Issue 10, p4227-4235, 9p
Publication Year :
2021

Abstract

Background: Previous studies have investigated weight loss caused by exercise following bariatric surgery. However, in most cases, the training program is poorly reported; the exercise type, volume, and intensity are briefly mentioned; and the sample size, selection criteria, and follow-up time vary greatly across studies. Purpose: The EFIBAR study aims to investigate over 1 year the effects of a 16-week supervised exercise program, initiated immediately after bariatric surgery, on weight loss (primary outcome), body composition, cardiometabolic risk, physical fitness, and quality of life in patients with severe/extreme obesity. Material and Methods: The EFIBAR study is a parallel-group, superiority, randomized controlled trial (RCT), comprising 80 surgery patients. Half of the participants, randomly selected, perform a 16-week supervised exercise program, including both strength and aerobic training, starting immediately after the surgery (7–14 days). For each participant, all primary and secondary outcomes are measured at three different time points: (i) before the surgery, (ii) after the intervention (≈4 months), and (iii) 1 year after the surgery. Conclusion: The EFIBAR study will provide new insights into the multidimensional benefits of exercise in adults with severe/extreme obesity following bariatric surgery. Trial Registration: EFIBAR randomized controlled trial was prospectively registered at Clinicaltrials.gov (NCT03497546) on April 13, 2018. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09608923
Volume :
31
Issue :
10
Database :
Complementary Index
Journal :
Obesity Surgery
Publication Type :
Academic Journal
Accession number :
152580233
Full Text :
https://doi.org/10.1007/s11695-021-05559-8